Navigation Links
Buckfire & Buckfire, P.C. Dangerous Drug Lawyers Now Accepting Michigan Actos Lawsuits

Southfield, MI (PRWEB) June 11, 2013

The dangerous drug legal team at the personal injury law firm of Buckfire & Buckfire, P.C. is now actively accepting Actos lawsuits for those patients allegedly suffering serious injuries after taking the prescribed diabetes drug. The dangerous drug lawyers are accepting all cases that involve patients who have been diagnosed with bladder cancer while taking Actos or within five years of their Actos usage.

Actos, also known as a pioglitazone, is a drug that is prescribed for treatment of diabetes, particularly Type 2 diabetes. However, even though Actos is known to be an effective drug in treating this medical condition, the drug has also been allegedly linked to bladder cancer. In fact, on June 15, 2011 the FDA have warned patients that the drug Actos may be associated with developing bladder cancer. (Click here to view the FDA Drug Safety Communication report on Actos).

Patients allegedly suffering from bladder after taking the drug Actos do have legal rights and may have a possible Actos lawsuit against the drug manufacturer, Takeda Pharmaceutical. These cases seek fair compensation to patients who have been allegedly harmed by the medication that was prescribed to them by their physicians.

“There are strict statute of limitations for filing a Michigan Actos lawsuit. If you miss a deadline your case will be lost forever. It is important when choosing your lawyer for your bladder cancer Actos case that you choose an attorney that has significant experience in dangerous drug cases and representing patients injured or harmed by a dangerous drug. At the law firm of Buckfire & Buckfire, P.C. our Michigan Actos lawyers work directly with other national law firms to win the best settlement for our clients,” says Partner and Attorney Lawrence J. Buckfire.

Patients taking Actos and their physicians should be fully aware of the alleged potential association between Actos and bladder cancer, as well as other side effects of the drug.


Buckfire & Buckfire, P.C. is a family-owned Michigan personal injury law firm representing patients who have been diagnosed with bladder cancer or allegedly suffering from bladder cancer during their Actos diabetes drug usage. Patients harmed do have legal rights and there may be legal ground to pursue a lawsuit. The Michigan Actos lawyers at the award winning law firm offers a free no obligation consultation and has a No Win No Fee guarantee, meaning there are no legal fees or costs until your case is settled or won.

To learn more about the Michigan Actos lawyers at Buckfire & Buckfire, P.C. call toll-free at (800) 606-1717 or visit the law firm website at

To view a recent video by the Buckfire & Buckfire, P.C. law firm on their active representation of Actos lawsuits visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Buckfire & Buckfire, P.C. Accident Attorneys Announce New Ugly Christmas Sweater Social Media Contest
2. Slip and Fall Accident Attorney At Buckfire & Buckfire, P.C. Makes Michigan Lawyers Weekly For Fall on Ice Settlement
3. Buckfire & Buckfire Motorcycle Attorney Meets with Legislators on Issues Affecting Injured Motorcyclists
4. Michigan Car Accident Attorneys at Buckfire & Buckfire, P.C. Sponsor Gala for Spinal Cord Injury Victims
5. Michigan Bike Accident Lawyers at Buckfire & Buckfire Celebrate Bicycle Helmet Safety Week
6. Michigan Car Accident Lawyer at Buckfire & Buckfire, P.C. Creates Drunk Driving Deaths Infographic
7. Buckfire & Buckfire, P.C. Dog Bite Lawyers in Michigan Discuss National Dog Bite Prevention Week
8. Buckfire & Buckfire, P.C. Michigan Hip Replacement Lawyers Now Accepting Stryker Hip Implant Lawsuits
9. Buckfire & Buckfire, P.C. Lawyers Now Accepting Michigan Mirena IUD Lawsuits
10. Research shows efficacy of treatment model developed at Women & Infants
11. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... Jobs in hospital medical laboratories and in ... by healthcare staffing agency Aureus Medical Group . These fields, as ... among those searching for healthcare jobs through the company’s website, , ...
(Date:11/26/2015)... Mass. (PRWEB) , ... November 26, 2015 , ... ... thorough second medical opinion process, participated in the 61st annual Employee Benefits Conference. ... Plans and took place Sunday, November 8th through Wednesday, November 11th, 2015. The ...
(Date:11/26/2015)... , ... November 26, 2015 ... ... platform for mental health and wellness consultation, has collaborated with Women’s Web ... address their reader’s queries on topics on mental and emotional well-being relationship, ...
(Date:11/25/2015)... OAK BROOK, Ill. (PRWEB) , ... November 25, ... ... sometimes larger and potentially more aggressive than those found on mammography, according to ... cases MRI findings of additional cancers not seen on mammography may necessitate a ...
(Date:11/25/2015)... ... November 25, 2015 , ... The holiday season ... and pleasing the palates of attendees is of the utmost importance. Whether you ... seasonal get-together, give these recipes a try this holiday season. , Turkey Croquettes ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Cell Surface Marker Testing Market: ...  report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/25/2015)... WOODBURY, N.Y. , Nov. 25, 2015  Linden ... access and optimizing treatment outcomes for patients suffering from ... its request for a Temporary Restraining Order (TRO) enjoining ... between the two companies. --> ... aggressively pursuing all of its legal options. ...
Breaking Medicine Technology: